Cardiovascular Drugs and Therapy

, Volume 29, Issue 4, pp 391–401 | Cite as

Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child

  • Ki Park
  • Janet Wei
  • Margo Minissian
  • C. Noel Bairey Merz
  • Carl J. Pepine


Adverse pregnancy conditions in women are common and have been associated with adverse cardiovascular and metabolic outcomes such as myocardial infarction and stroke. As risk stratification in women is often suboptimal, recognition of non-traditional risk factors such as hypertensive disorders of pregnancy and premature delivery has become increasingly important. Additionally, such conditions may also increase the risk of cardiovascular disease in the children of afflicted women. In this review, we aim to highlight these conditions, along with infertility, and the association between such conditions and various cardiovascular outcomes and related maternal risk along with potential translation of risk to offspring. We will also discuss proposed mechanisms driving these associations as well as potential opportunities for screening and risk modification.


Pregnancy Preterm birth Hypertension Stroke Myocardial infarction 



This work was supported by contracts from the National Heart, Lung and Blood Institutes nos. N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164, grants U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, T32HL116273, F31NR015725, R01 HL090957, 1R03AG032631 from the National Institute on Aging, GCRC grant MO1-RR00425 from the National Center for Research Resources, the National Center for Advancing Translational Sciences Grant UL1TR000124 and UL1TR000064, and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ, The Women’s Guild of Cedars-Sinai Medical Center, Los Angeles, CA, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA, and QMED, Inc., Laurence Harbor, NJ, the Edythe L. Broad and the Constance Austin Women’s Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Women’s Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Women’s Health Research (SWHR), Washington, D.C., The Linda Joy Pollin Women’s Heart Health Program, and the Erika Glazer Women’s Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


  1. 1.
    Sharaf B, Wood T, Shaw L, et al. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation (WISE) angiographic core laboratory. Am Heart J. 2013;166:134–41.PubMedCentralPubMedGoogle Scholar
  2. 2.
    Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101–11.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Pepine CJ. Multiple causes for ischemia without obstructive coronary artery disease: not a short list. Circulation. 2015;131:1044–6.PubMedGoogle Scholar
  4. 4.
    Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation. 2008;118:2243–51.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Goff Jr DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63:2935–59.PubMedGoogle Scholar
  6. 6.
    Capeless EL, Clapp JF. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol. 1989;161:1449–53.PubMedGoogle Scholar
  7. 7.
    Katz R, Karliner JS, Resnik R. Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation. 1978;58:434–41.PubMedGoogle Scholar
  8. 8.
    Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256:H1060–5.PubMedGoogle Scholar
  9. 9.
    Robson SC, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94:1028–39.PubMedGoogle Scholar
  10. 10.
    van Oppen AC, Stigter RH, Bruinse HW. Cardiac output in normal pregnancy: a critical review. Obstet Gynecol. 1996;87:310–8.PubMedGoogle Scholar
  11. 11.
    Fialova L, Malbohan I, Kalousova M, et al. Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest. 2006;66:121–7.PubMedGoogle Scholar
  12. 12.
    Hastie CE, Smith GC, Mackay DF, Pell JP. Association between preterm delivery and subsequent C-reactive protein: a retrospective cohort study. Am J Obstet Gynecol. 2011;205(556):e1–4.PubMedGoogle Scholar
  13. 13.
    Brizzi P, Tonolo G, Esposito F, et al. Lipoprotein metabolism during normal pregnancy. Am J Obstet Gynecol. 1999;181:430–4.PubMedGoogle Scholar
  14. 14.
    Piechota W, Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992;45:27–35.PubMedGoogle Scholar
  15. 15.
    Wiznitzer A, Mayer A, Novack V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol. 2009;201(482):e1–8.Google Scholar
  16. 16.
    Butte NF, Hsu HW, Thotathuchery M, et al. Protein metabolism in insulin-treated gestational diabetes. Diabetes Care. 1999;22:806–11.PubMedGoogle Scholar
  17. 17.
    Homko CJ, Sivan E, Reece EA, Boden G. Fuel metabolism during pregnancy. Semin Reprod Endocrinol. 1999;17:119–25.PubMedGoogle Scholar
  18. 18.
    Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth. 2010;10:56.PubMedCentralPubMedGoogle Scholar
  19. 19.
    Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the avon longitudinal study of parents and children. Circulation. 2012;125:1367–80.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women’s future cardiovascular health: an underused opportunity to improve women’s health? Epidemiol Rev. 2014;36:57–70.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Chandra A, Copen CE, Stephen EH. Infertility and impaired fecundity in the United States, 1982–2010: data from the National Survey of Family Growth. Natl Health Stat Report. 2013:1–18, 1 p following 9.Google Scholar
  22. 22.
    Messerlian C, Maclagan L, Basso O. Infertility and the risk of adverse pregnancy outcomes: a systematic review and meta-analysis. Hum Reprod. 2013;28:125–37.PubMedGoogle Scholar
  23. 23.
    Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a national institute of child health and human development workshop. Obstet Gynecol. 2007;109:967–77.PubMedGoogle Scholar
  24. 24.
    Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med. 2004;21:103–13.PubMedGoogle Scholar
  25. 25.
    Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care. 2007;30 Suppl 2:S251–60.PubMedGoogle Scholar
  26. 26.
    Carr DB, Utzschneider KM, Hull RL, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care. 2006;29:2078–83.PubMedGoogle Scholar
  27. 27.
    Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–9.PubMedGoogle Scholar
  28. 28.
    Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the national health interview survey. Diabetes Care. 2012;35:1252–7.PubMedCentralPubMedGoogle Scholar
  29. 29.
    Gunderson EP, Chiang V, Pletcher MJ, et al. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study. J Am Heart Assoc. 2014;3, e000490.PubMedCentralPubMedGoogle Scholar
  30. 30.
    Gobl CS, Bozkurt L, Yarragudi R, et al. Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus. Cardiovasc Diabetol. 2014;13:138.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Committee on Practice Bulletins--Obstetrics. Practice bulletin No. 137: gestational diabetes mellitus. Obstet Gynecol. 2013;122:406–16.Google Scholar
  32. 32.
    Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens. 2008;21:521–6.PubMedGoogle Scholar
  33. 33.
    Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–31.Google Scholar
  34. 34.
    Hernandez-Diaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009;338:b2255.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American heart association. J Am Coll Cardiol. 2011;57:1404–23.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Yeh JS, Cheng HM, Hsu PF, et al. Synergistic effect of gestational hypertension and postpartum incident hypertension on cardiovascular health: a nationwide population study. J Am Heart Assoc. 2014;3, e001008.PubMedCentralPubMedGoogle Scholar
  37. 37.
    Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.PubMedCentralPubMedGoogle Scholar
  38. 38.
    McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156:918–30.PubMedGoogle Scholar
  39. 39.
    Lykke JA, Langhoff-Roos J, Sibai BM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944–51.PubMedGoogle Scholar
  40. 40.
    Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166–71.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122:579–84.PubMedGoogle Scholar
  42. 42.
    Chambers JC, Fusi L, Malik IS, et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285:1607–12.PubMedGoogle Scholar
  43. 43.
    Gilbert JS, Ryan MJ, LaMarca BB, et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294:H541–50.PubMedGoogle Scholar
  44. 44.
    Stekkinger E, Scholten R, van der Vlugt MJ, et al. Metabolic syndrome and the risk for recurrent pre-eclampsia: a retrospective cohort study. BJOG. 2013;120:979–86.PubMedGoogle Scholar
  45. 45.
    Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84.PubMedGoogle Scholar
  46. 46.
    Perng W, Stuart J, Rifas-Shiman SL, et al. Preterm birth and long-term maternal cardiovascular health. Ann Epidemiol. 2015;25:40–5.PubMedGoogle Scholar
  47. 47.
    Davey Smith G, Hart C, Ferrell C, et al. Birth weight of offspring and mortality in the Renfrew and Paisley study: prospective observational study. BMJ. 1997;315:1189–93.PubMedCentralPubMedGoogle Scholar
  48. 48.
    Davey Smith G, Hypponen E, Power C, Lawlor DA. Offspring birth weight and parental mortality: prospective observational study and meta-analysis. Am J Epidemiol. 2007;166:160–9.PubMedGoogle Scholar
  49. 49.
    Kaijser M, Bonamy AK, Akre O, et al. Perinatal risk factors for ischemic heart disease: disentangling the roles of birth weight and preterm birth. Circulation. 2008;117:405–10.PubMedGoogle Scholar
  50. 50.
    Smith GD, Whitley E, Gissler M, Hemminki E. Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet. 2000;356:2066–7.PubMedGoogle Scholar
  51. 51.
    Kessous R, Shoham-Vardi I, Pariente G, Holcberg G, Sheiner E. An association between preterm delivery and long-term maternal cardiovascular morbidity. Am J Obstet Gynecol. 2013;209(368):e1–8.PubMedGoogle Scholar
  52. 52.
    Catov JM, Dodge R, Barinas-Mitchell E, et al. Prior preterm birth and maternal subclinical cardiovascular disease 4 to 12 years after pregnancy. J Womens Health (Larchmt). 2013;22:835–43.Google Scholar
  53. 53.
    Catov JM, Wu CS, Olsen J, et al. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20:604–9.PubMedCentralPubMedGoogle Scholar
  54. 54.
    Lykke JA, Paidas MJ, Damm P, et al. Preterm delivery and risk of subsequent cardiovascular morbidity and type-II diabetes in the mother. BJOG. 2010;117:274–81.PubMedGoogle Scholar
  55. 55.
    Hamilton BE, Hoyert DL, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2010–2011. Pediatrics. 2013;131:548–58.PubMedGoogle Scholar
  56. 56.
    Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2007. Natl Vital Stat Rep. 2010;58:1–85.PubMedGoogle Scholar
  57. 57.
    Bukowski R, Davis KE, Wilson PW. Delivery of a small for gestational age infant and greater maternal risk of ischemic heart disease. PLoS One. 2012;7, e33047.PubMedCentralPubMedGoogle Scholar
  58. 58.
    Xu J, Barinas-Mitchell E, Kuller LH, Youk AO, Catov JM. Maternal hypertension after a low-birth-weight delivery differs by race/ethnicity: evidence from the national health and nutrition examination survey (NHANES) 1999–2006. PLoS One. 2014;9, e104149.PubMedCentralPubMedGoogle Scholar
  59. 59.
    Hastie CE, Smith GC, Mackay DF, Pell JP. Maternal risk of ischaemic heart disease following elective and spontaneous pre-term delivery: retrospective cohort study of 750 350 singleton pregnancies. Int J Epidemiol. 2011;40:914–9.PubMedGoogle Scholar
  60. 60.
    Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323:1213–7.PubMedCentralPubMedGoogle Scholar
  61. 61.
    Catov JM, Dodge R, Yamal JM, et al. Prior preterm or small-for-gestational-age birth related to maternal metabolic syndrome. Obstet Gynecol. 2011;117:225–32.PubMedCentralPubMedGoogle Scholar
  62. 62.
    Catov JM, Newman AB, Sutton-Tyrrell K, et al. Parity and cardiovascular disease risk among older women: how do pregnancy complications mediate the association? Ann Epidemiol. 2008;18:873–9.PubMedCentralPubMedGoogle Scholar
  63. 63.
    Humphries KH, Westendorp IC, Bots ML, et al. Parity and carotid artery atherosclerosis in elderly women: the Rotterdam study. Stroke. 2001;32:2259–64.PubMedGoogle Scholar
  64. 64.
    Lawlor DA, Emberson JR, Ebrahim S, et al. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British women’s heart and health study and the British regional heart study. Circulation. 2003;107:1260–4.PubMedGoogle Scholar
  65. 65.
    Ness RB, Harris T, Cobb J, et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med. 1993;328:1528–33.PubMedGoogle Scholar
  66. 66.
    Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol. 1992;136:408–16.PubMedGoogle Scholar
  67. 67.
    Parikh NI, Cnattingius S, Dickman PW, et al. Parity and risk of later-life maternal cardiovascular disease. Am Heart J. 2010;159:215–21.PubMedGoogle Scholar
  68. 68.
    Parikh NI, Cnattingius S, Mittleman MA, Ludvigsson JF, Ingelsson E. Subfertility and risk of later life maternal cardiovascular disease. Hum Reprod. 2012;27:568–75.PubMedCentralPubMedGoogle Scholar
  69. 69.
    Kharazmi E, Dossus L, Rohrmann S, Kaaks R. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart. 2011;97:49–54.PubMedGoogle Scholar
  70. 70.
    Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565–92.PubMedGoogle Scholar
  71. 71.
    Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745–9.PubMedGoogle Scholar
  72. 72.
    Stanczyk FZ. Diagnosis of hyperandrogenism: biochemical criteria. Best Pract Res Clin Endocrinol Metab. 2006;20:177–91.PubMedGoogle Scholar
  73. 73.
    Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1929–35.PubMedGoogle Scholar
  74. 74.
    Dokras A, Bochner M, Hollinrake E, et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005;106:131–7.PubMedGoogle Scholar
  75. 75.
    Ehrmann DA, Liljenquist DR, Kasza K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:48–53.PubMedGoogle Scholar
  76. 76.
    DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83:1454–60.PubMedGoogle Scholar
  77. 77.
    Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165–74.PubMedGoogle Scholar
  78. 78.
    Colilla S, Cox NJ, Ehrmann DA. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab. 2001;86:2027–31.PubMedGoogle Scholar
  79. 79.
    Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22:141–6.PubMedGoogle Scholar
  80. 80.
    Ehrmann DA, Kasza K, Azziz R, et al. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:66–71.PubMedGoogle Scholar
  81. 81.
    Ehrmann DA, Sturis J, Byrne MM, et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995;96:520–7.PubMedCentralPubMedGoogle Scholar
  82. 82.
    Lo JC, Feigenbaum SL, Yang J, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1357–63.PubMedGoogle Scholar
  83. 83.
    Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86:1175–80.PubMedGoogle Scholar
  84. 84.
    Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:36–42.PubMedGoogle Scholar
  85. 85.
    Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab. 2001;86:517–20.PubMedGoogle Scholar
  86. 86.
    Legro RS, Azziz R, Ehrmann D, et al. Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab. 2003;88:5137–44.PubMedGoogle Scholar
  87. 87.
    Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. 2001;111:607–13.PubMedGoogle Scholar
  88. 88.
    Boulman N, Levy Y, Leiba R, et al. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2160–5.PubMedGoogle Scholar
  89. 89.
    Sprung VS, Atkinson G, Cuthbertson DJ, et al. Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clin Endocrinol (Oxf). 2013;78:438–46.Google Scholar
  90. 90.
    Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med. 1997;126:32–5.PubMedGoogle Scholar
  91. 91.
    Christian RC, Dumesic DA, Behrenbeck T, et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:2562–8.PubMedGoogle Scholar
  92. 92.
    Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol. 2000;20:2414–21.PubMedGoogle Scholar
  93. 93.
    Wang ET, Cirillo PM, Vittinghoff E, et al. Menstrual irregularity and cardiovascular mortality. J Clin Endocrinol Metab. 2011;96:E114–8.PubMedCentralPubMedGoogle Scholar
  94. 94.
    de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011;17:495–500.PubMedGoogle Scholar
  95. 95.
    Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf). 2000;52:595–600.Google Scholar
  96. 96.
    Solomon CG, Hu FB, Dunaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab. 2002;87:2013–7.PubMedGoogle Scholar
  97. 97.
    Jovanovic VP, Carmina E, Lobo RA. Not all women diagnosed with PCOS share the same cardiovascular risk profiles. Fertil Steril. 2010;94:826–32.PubMedGoogle Scholar
  98. 98.
    Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol. 1998;51:581–6.PubMedGoogle Scholar
  99. 99.
    Udell JA, Lu H, Redelmeier DA. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol. 2013;62:1704–12.PubMedGoogle Scholar
  100. 100.
    Kallen B, Finnstrom O, Nygren KG, Otterblad Olausson P, Wennerholm UB. In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality. BJOG. 2005;112:1529–35.PubMedGoogle Scholar
  101. 101.
    Venn A, Hemminki E, Watson L, Bruinsma F, Healy D. Mortality in a cohort of IVF patients. Hum Reprod. 2001;16:2691–6.PubMedGoogle Scholar
  102. 102.
    D'Agostino Sr RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117:743–53.PubMedGoogle Scholar
  103. 103.
    Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA. 2007;297:611–9.PubMedGoogle Scholar
  104. 104.
    Stuart JJ, Bairey Merz CN, Berga SL, et al. Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Womens Health (Larchmt). 2013;22:37–47.Google Scholar
  105. 105.
    Visentin S, Grumolato F, Nardelli GB, et al. Early origins of adult disease: low birth weight and vascular remodeling. Atherosclerosis. 2014;237:391–9.PubMedGoogle Scholar
  106. 106.
    Fowden AL, Giussani DA, Forhead AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006;21:29–37.Google Scholar
  107. 107.
    Leeson CP, Whincup PH, Cook DG, et al. Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation. 1997;96:2233–8.PubMedGoogle Scholar
  108. 108.
    Napoli C, D'Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680–90.PubMedCentralPubMedGoogle Scholar
  109. 109.
    Napoli C, Witztum JL, de Nigris F, et al. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation. 1999;99:2003–10.PubMedGoogle Scholar
  110. 110.
    Napoli C, Infante T, Casamassimi A. Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage. Cardiovasc Res. 2011;92:367–74.PubMedGoogle Scholar
  111. 111.
    Bonamy AK, Kallen K, Norman M. High blood pressure in 2.5-year-old children born extremely preterm. Pediatrics. 2012;129:e1199–204.PubMedGoogle Scholar
  112. 112.
    Hovi P, Andersson S, Eriksson JG, et al. Glucose regulation in young adults with very low birth weight. N Engl J Med. 2007;356:2053–63.PubMedGoogle Scholar
  113. 113.
    Johansson S, Iliadou A, Bergvall N, et al. Risk of high blood pressure among young men increases with the degree of immaturity at birth. Circulation. 2005;112:3430–6.PubMedGoogle Scholar
  114. 114.
    Ueda P, Cnattingius S, Stephansson O, et al. Cerebrovascular and ischemic heart disease in young adults born preterm: a population-based Swedish cohort study. Eur J Epidemiol. 2014;29:253–60.PubMedGoogle Scholar
  115. 115.
    Abitbol CL, Rodriguez MM. The long-term renal and cardiovascular consequences of prematurity. Nat Rev Nephrol. 2012;8:265–74.PubMedGoogle Scholar
  116. 116.
    Bonamy AK, Martin H, Jorneskog G, Norman M. Lower skin capillary density, normal endothelial function and higher blood pressure in children born preterm. J Intern Med. 2007;262:635–42.PubMedGoogle Scholar
  117. 117.
    Cheung YF, Wong KY, Lam BC, Tsoi NS. Relation of arterial stiffness with gestational age and birth weight. Arch Dis Child. 2004;89:217–21.PubMedCentralPubMedGoogle Scholar
  118. 118.
    Oren A, Vos LE, Bos WJ, et al. Gestational age and birth weight in relation to aortic stiffness in healthy young adults: two separate mechanisms? Am J Hypertens. 2003;16:76–9.PubMedGoogle Scholar
  119. 119.
    Tauzin L, Rossi P, Giusano B, et al. Characteristics of arterial stiffness in very low birth weight premature infants. Pediatr Res. 2006;60:592–6.PubMedGoogle Scholar
  120. 120.
    Jaddoe VW, de Jonge LL, Hofman A, et al. First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. BMJ. 2014;348:g14.PubMedCentralPubMedGoogle Scholar
  121. 121.
    Bonamy AK, Bendito A, Martin H, et al. Preterm birth contributes to increased vascular resistance and higher blood pressure in adolescent girls. Pediatr Res. 2005;58:845–9.PubMedGoogle Scholar
  122. 122.
    Higgins M, Keller J, Moore F, et al. Studies of blood pressure in Tecumseh, Michigan. I. Blood pressure in young people and its relationship to personal and familial characteristics and complications of pregnancy in mothers. Am J Epidemiol. 1980;111:142–55.PubMedGoogle Scholar
  123. 123.
    Langford HG, Watson RL. Prepregnant blood pressure, hypertension during pregnancy, and later blood pressure of mothers and offspring. Hypertension. 1980;2:130–3.PubMedGoogle Scholar
  124. 124.
    Palti H, Rothschild E. Blood pressure and growth at 6 years of age among offsprings of mothers with hypertension of pregnancy. Early Hum Dev. 1989;19:263–9.PubMedGoogle Scholar
  125. 125.
    Seidman DS, Laor A, Gale R, et al. Pre-eclampsia and offspring’s blood pressure, cognitive ability and physical development at 17-years-of-age. Br J Obstet Gynaecol. 1991;98:1009–14.PubMedGoogle Scholar
  126. 126.
    Tenhola S, Rahiala E, Halonen P, Vanninen E, Voutilainen R. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr Res. 2006;59:320–4.PubMedGoogle Scholar
  127. 127.
    Fraser A, Nelson SM, Macdonald-Wallis C, Sattar N, Lawlor DA. Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension. 2013;62:614–20.PubMedGoogle Scholar
  128. 128.
    Davis EF, Lazdam M, Lewandowski AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129:e1552–61.PubMedGoogle Scholar
  129. 129.
    Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke. 2009;40:1176–80.PubMedGoogle Scholar
  130. 130.
    Ceelen M, van Weissenbruch MM, Vermeiden JP, van Leeuwen FE, de Waal HA D-v. Cardiometabolic differences in children born after in vitro fertilization: follow-up study. J Clin Endocrinol Metab. 2008;93:1682–8.PubMedGoogle Scholar
  131. 131.
    Scherrer U, Rimoldi SF, Rexhaj E, et al. Systemic and pulmonary vascular dysfunction in children conceived by assisted reproductive technologies. Circulation. 2012;125:1890–6.PubMedGoogle Scholar
  132. 132.
    Valenzuela-Alcaraz B, Crispi F, Bijnens B, et al. Assisted reproductive technologies are associated with cardiovascular remodeling in utero that persists postnatally. Circulation. 2013;128:1442–50.PubMedGoogle Scholar
  133. 133.
    Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010;27:121–8.PubMedCentralPubMedGoogle Scholar
  134. 134.
    Xu GF, Zhang JY, Pan HT, et al. Cardiovascular dysfunction in offspring of ovarian-hyperstimulated women and effects of estradiol and progesterone: a retrospective cohort study and proteomics analysis. J Clin Endocrinol Metab. 2014;99:E2494–503.PubMedGoogle Scholar
  135. 135.
    Torrens C, Snelling TH, Chau R, et al. Effects of pre- and periconceptional undernutrition on arterial function in adult female sheep are vascular bed dependent. Exp Physiol. 2009;94:1024–33.PubMedGoogle Scholar
  136. 136.
    Norman M. Low birth weight and the developing vascular tree: a systematic review. Acta Paediatr. 2008;97:1165–72.PubMedGoogle Scholar
  137. 137.
    Reveret M, Boivin A, Guigonnis V, Audibert F, Nuyt AM. Preeclampsia: effect on newborn blood pressure in the 3 days following preterm birth: a cohort study. J Hum Hypertens. 2015;29:115–21.PubMedGoogle Scholar
  138. 138.
    Washburn LK, Brosnihan KB, Chappell MC, et al. The renin-angiotensin-aldosterone system in adolescent offspring born prematurely to mothers with preeclampsia. J Renin Angiotensin Aldosterone Syst. 2014.Google Scholar
  139. 139.
    Lazdam M, de la Horra A, Pitcher A, et al. Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism? Hypertension. 2010;56:159–65.PubMedGoogle Scholar
  140. 140.
    Davis EF, Newton L, Lewandowski AJ, et al. Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies. Clin Sci (Lond). 2012;123:53–72.Google Scholar
  141. 141.
    Geelhoed JJ, Fraser A, Tilling K, et al. Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the avon longitudinal study of parents and children. Circulation. 2010;122:1192–9.PubMedGoogle Scholar
  142. 142.
    Jayet PY, Rimoldi SF, Stuber T, et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation. 2010;122:488–94.PubMedGoogle Scholar
  143. 143.
    Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC). Eur Heart J. 2011;32:3147–97.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Ki Park
    • 1
  • Janet Wei
    • 2
  • Margo Minissian
    • 2
  • C. Noel Bairey Merz
    • 2
  • Carl J. Pepine
    • 1
  1. 1.Division of Cardiovascular MedicineUniversity of FloridaGainesvilleUSA
  2. 2.Barbra Streisand Women’s Heart CenterCedars-Sinai Heart InstituteLos AngelesUSA

Personalised recommendations